Justification of Methodological Approaches to Identification Testing of Biomedical Cell Products

The manufacturer (developer) has to prepare a specification for each newly developed biomedical cell product (BCP) that has passed the stage of preclinical studies. The specification is included into the registration dossier when applying for marketing authorisation of a BCP. In accordance with the...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Melnikova, O. A. Rachinskaya, G. A. Trusov, M. D. Khorolsky, I. S. Semenova, N. V. Tereshkina, V. A. Merkulov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2019-03-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/203
Tags: Add Tag
No Tags, Be the first to tag this record!